Journal of chemotherapy (Florence, Italy)

Keyphrases

Publications

2024

Uğur Önal, Ülkü Tüzemen, Pınar Küçükdemirci Kaya, Remzi İşçimen, Nermin Kelebek Girgin, Cüneyt Özakın, Ferda Kahveci, Halis Akalın
A comparative study of ceftazidime/avibactam-based and fosfomycin plus meropenem-based regimens for managing infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients. Journal of chemotherapy (Florence, Italy) (2024)
Gaoqi Xu, Xin Liu, Jiaqi Wang, Yuqing Mei, Dihong Yang, Chaoneng He, Like Zhong, Junfeng Zhu, Haiying Ding, Luo Fang
Evaluation of omadacycline regimens for community-acquired bacterial pneumonia patients infected with Staphylococcus Aureus by pharmacokinetic/pharmacodynamic analysis. Journal of chemotherapy (Florence, Italy) (2024)
Makito Miyake, Nobutaka Nishimura, Yuki Oda, Tatsuki Miyamoto, Mitsuru Tomizawa, Takuto Shimizu, Shunta Hori, Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, Kazumasa Torimoto, Tomomi Fujii, Nobumichi Tanaka, Kiyohide Fujimoto
Dysgeusia in patients with advanced urothelial carcinoma receiving enfortumab vedotin, platinum-based chemotherapy, or immune check point inhibitors: time-course assessment using chemotherapy-induced taste alteration scale. Journal of chemotherapy (Florence, Italy) (2024)
Mengying Zhang, Zhonghua An, Yiming Jiang, Meijiao Wei, Xiangbo Li, Yifan Wang, Hongbo Wang, Yanling Gong
Self-assembled redox-responsive BRD4 siRNA nanoparticles: fomulation and its in vitro delivery in gastric cancer cells. Journal of chemotherapy (Florence, Italy) (2024)
Joseph M Blondeau, Leah D Blondeau, Shantelle D Fitch
In vitro killing of drug susceptible and multidrug resistant bacteria by amikacin considering pulmonary drug concentrations based on an inhaled formulation. Journal of chemotherapy (Florence, Italy) (2024)
Avner Dagan, Danny Epstein, Ami Neuberger, Jonathan Isenberg
Amikacin treatment in urinary tract infection patients: evaluating the risk of acute kidney injury - a retrospective cohort study. Journal of chemotherapy (Florence, Italy) (2024)
Hasan Cenk Mirza, Özlem Öğüç Şanlı
Evaluation of in vitro activity of ceftaroline, ceftobiprole and their combination with trimethoprim/sulfamethoxazole against MRSA isolates: a two center study. Journal of chemotherapy (Florence, Italy) (2024)
Kátia Duarte Vital, Luiz Octavio Pires, Bruno Gallotti, Janayne Luihan Silva, Luís Cláudio Lima de Jesus, Jacqueline Isaura Alvarez-Leite, Ênio Ferreira, Vasco Ariston de Carvalho Azevedo, Flaviano Dos Santos Martins, Valbert Nascimento Cardoso, Simone Odilia Antunes Fernandes
Atorvastatin attenuates intestinal mucositis induced by 5-fluorouracil in mice by modulating the epithelial barrier and inflammatory response. Journal of chemotherapy (Florence, Italy) (2024)
Muhammad Saleem Faisal, Imran Hussain, Muhammad Abdullah Ikram, Syed Babar Shah, Abdul Rehman, Wajid Iqbal
Irinotecan dosing and pharmacogenomics: a comprehensive exploration based on UGT1A1 variants and emerging insights. Journal of chemotherapy (Florence, Italy) (2024)
Yosuke Masamoto, Akira Honda, Aya Shinozaki-Ushiku, Tetsuo Ushiku, Mineo Kurokawa
Long-term remission after upfront autologous hematopoietic stem cell transplant for CD5 + diffuse large-B cell lymphoma. Journal of chemotherapy (Florence, Italy) (2024)
Mingyang Yang, Junzhao Liu, Linna Luo, Kaili Dai
Comparison of bamlanivimab with or without etesevimab and casirivimab-imdevimab in clinical outcomes in patients with COVID-19: a systematic review and meta-analysis. Journal of chemotherapy (Florence, Italy) (2024)
Yangqingqing Zhou, Hui Wang, Jiao Yang, Fan Wang, Danfeng Dong, Xiaoai Zhao, Le Wang, Ruiyuan He, Zhiping Ruan, Jin Yang
Comparison of the prognostic effect of pyrotinib plus trastuzumab and chemotherapy different lines therapy in HER2-positive advanced breast cancer. Journal of chemotherapy (Florence, Italy) (2024)
Om Elez Bouhniz, Abderraouf Kenani
Potential role of genetic polymorphisms in neoadjuvant chemotherapy response in breast cancer. Journal of chemotherapy (Florence, Italy) (2024)
Aysel Pehlivanlı, Tuğba Y Yalçın, Fatma İrem Yeşiler, Helin Şahintürk, Özlem K Azap, Pınar Zeyneloğlu, Bilgen Başgut
Antimicrobial dosing recommendations during continuous renal replacement therapy: different databases, different doses. Journal of chemotherapy (Florence, Italy) (2024)
Hyoung-Tae Kim, Cheon Hoo Jun, Si-Ho Kim, Yu-Mi Wi
Clinical scoring model for predicting cefotaxime-resistance in Klebsiella pneumoniae bacteremia: development and validation based on portal of entry. Journal of chemotherapy (Florence, Italy) (2024)
Xiang-Di Tan, Cui-Fang Luo, Si-Yu Liang
Antihyperlipidemic drug rosuvastatin suppressed tumor progression and potentiated chemosensitivity by downregulating CCNA2 in lung adenocarcinoma. Journal of chemotherapy (Florence, Italy) (2024)
Hamdy A Azim, Mariam A Saleh, Passant Essam Eldin, Ahmed A M Abdelhafeez, Mohamed Hassan, Loay Kassem
Combination of metronomic capecitabine and letrozole in metastatic hormone receptor positive, HER2 negative breast cancer: a randomized phase II trial. Journal of chemotherapy (Florence, Italy) (2024)
Zohaib Ijaz, Doga Kahramangil, Kriti Gera, Ilyas Sahin
Durable pembrolizumab response in metastatic MSS ARID1A-mutant undifferentiated carcinoma of the esophagus. Journal of chemotherapy (Florence, Italy) (2024)
E Tejedor Tejada, S Gonzalez Suárez, T Lizondo López, C López-Cabezas, D Soy Muner
Alternatives for the administration of oral antineoplastics in patients with swallowing difficulties. Journal of chemotherapy (Florence, Italy) (2024)
Thierry Landre, Christos Chouaïd, Nassyma Sadaoui, Djamila Bouharati, Chérifa Taleb
Clinical benefit of anti-PD-1/PD-L1 plus chemotherapy in first-line treatment for patients over the age of 65 or 75 with metastatic non-small cell lung cancer (NSCLC). Journal of chemotherapy (Florence, Italy) (2024)
Osman Köstek, Ahmet Demirel, Muhammet Bekir Hacıoğlu, Didem Tastekin, Senem Karabulut, Abidin Gündogdu, Nadiye Sever, Murat Ayhan, Abdussamed Çelebi, Nargiz Majidova, Alper Yaşar, Yeşim Ağyol, Pınar Erel, Erkam Kocaaslan, Ali Kaan Güren, Rukiye Arıkan, Selver Isık, Ozlem Ercelep, Sema Sezgin Goksu, Celal Alandag, İrem Bilgetekin, Burcu Caner, Ahmet Bilge Sahin, Ahmet Gulmez, Baran Akagunduz, Fatih Kose, Muhammet Ali Kaplan, Ender Dogan, Teoman Sakalar, Deniz Can Guven, Mustafa Gurbuz, Yakup Ergun, Mustafa Karaagac, Sema Turker, Ozlem Ozkul, Birol Yıldız, Süleyman Sahin, Atike Gokcen Demiray, Murat Sari, Bülent Erdogan, İlhan Hacıbekiroglu, Ömür Berna Çakmak Öksüzoğlu, Saadettin Kilickap, Ahmet Bilici, İbrahim Vedat Bayoglu, Sernaz Topaloglu, İrfan Cicin
The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing. Journal of chemotherapy (Florence, Italy) (2024)
Erying Zhang, Haifei Li, Caiyun Liu, Haikun Zhou, Bo Liu, Chengbao Feng
Clinical value of circulating tumour cells in evaluating the efficacy of continuous hepatic arterial infusion among colorectal cancer patients. Journal of chemotherapy (Florence, Italy) (2024)
Carlo Pallotto, Andrea Tommasi, Margherita Albagini, Giovanni Genga, Elisabetta Svizzeretto, Anna Gidari, Sara Tordi, Daniela Francisci
Chronic antibiotic suppressive therapy with dalbavancin: a case series. Journal of chemotherapy (Florence, Italy) (2024)
Fujun Zhang, Juan Wang, Haoyu Li, Xiaoyu Luo, Qiuyue Xu, Lin Liu, Yunmin Xu, Kai Yang, Zijie Liu, Rong Gong
Blocking lncRNA HCG18 re-sensitizes Taxol resistant lung cancer cells to Taxol through modulating the miR-34a-5p/HDAC1 axis. Journal of chemotherapy (Florence, Italy) (2024)
Caner Acar, Gökhan Sahin, Haydar Çagatay Yüksel, Burçak Karaca
Rare immune-related adverse effect of pembrolizumab: pulmonary hypertension. Journal of chemotherapy (Florence, Italy) (2024)
Gizem Damla Yalcin, Pelin Mutlu, Hasan Huseyin Kazan, Ufuk Gunduz
Differential synergistic effects of palbociclib and doxorubicin on doxorubicin-resistant cancer cells with diverse tumor origins. Journal of chemotherapy (Florence, Italy) (2024)
Noriaki Kataoka, Takeo Hata, Kouichi Hosomi, Atsushi Hirata, Satoe Fujiwara, Emi Goto, Masami Nishihara, Masahide Ohmichi, Masashi Neo
Predictors of olaparib discontinuation owing to adverse drug events in patients with ovarian, peritoneal, or fallopian tube cancer: a retrospective observational study. Journal of chemotherapy (Florence, Italy) (2024)
Rui Wu, Xuechang Wang, Pumei Cui, Wei Chen, Wanqi Yang, Yong Lai
Efficacy and safety of generic cefoperazone/sulbactam versus branded cefoperazone/sulbactam in the treatment of bacterial infections: a systematic review and meta-analysis. Journal of chemotherapy (Florence, Italy) (2024)
Daniel Park, Alec M Chan-Golston, Yueqi Yan, Farris Al-Manaseer, Mojtaba Akhtari
Meta-analysis of the efficacy and adverse effects of acalabrutinib in the management of relapsed/refractory chronic lymphocytic leukemia. Journal of chemotherapy (Florence, Italy) (2024)
Xiao-Chen Wei, Ming-Feng Zhao, Xia Xiao
Evaluating omadacycline dosing regimens against drug-resistant pathogens including Staphylococcus aureus , Streptococcus pneumoniae and Haemophilus influenzae in adults: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation. Journal of chemotherapy (Florence, Italy) (2024)
Yazed Saleh Alsowaida, Ahmed Alsolami, Thamer A Almangour
Daptomycin and ceftaroline combination for the treatment of persistent methicillin-resistant Staphylococcus aureus bloodstream infections: a case series and literature review. Journal of chemotherapy (Florence, Italy) (2024)
Hasan Cagrı Yıldırım, Caner Kapar, Baris Koksal, Mustafa Seyyar, Pervin Can Sanci, Murad Guliyev, Perihan Perkin, Mustafa Buyukkor, Sendag Yaslikaya, Nargiz Majidova, Merve Keskinkilic, Duygu Ozaskin, Tugay Avci, Tugce Kubra Gunes, Murat Arcagok, Alper Topal, Gul Sema Yildiran Keskin, Gozde Kavgaci, Nilgun Yildirim, Ozde Melisa Celayir, Nilufer Avci, Ferit Aslan, Ali Alkan, Mert Erciyestepe, Muhammet Cengiz, Metin Pehlivan, Ahmet Gulmez, Ismail Beypinar, Tugba Basoglu Tuylu, Erkan Kayikcioglu, Elvin Chalabiyev, Serdal Turhal, Halil Goksel Guzel, Eyyup Ayas, Mustafa Sahbazlar, Ozgecan Dulgar, Hacer Demir, Tugba Yavuzsen, Vedat Bayoglu, Derya Kivrak Salim, Banu Ozturk, Feyyaz Ozdemir, Oguz Kara, Berna Oksuzoglu, Oznur Bal, Nebi Serkan Demirci, Mesut Yilmaz, Devrim Cabuk, Sercan Aksoy
Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study. Journal of chemotherapy (Florence, Italy) (2024)
Zrinka Bošnjak, Henrik Hasman, Frank Hansen, Anette M Hammerum, Louise Roer, Ivana Jurić, Ana Budimir
Co-occurrence of triple carbapenemase genes, bla VIM-2 , bla NDM-1 , and bla OXA-48 in Enterobacter hormaechei clinical isolates -first report from Croatia. Journal of chemotherapy (Florence, Italy) (2024)
Mohamad Abou Chakra, Mohamad Moussa, Michael A O'Donnell
Intravesical sequential gemcitabine/docetaxel for non-muscle invasive bladder cancer: tips and tricks for better efficacy and tolerability. Journal of chemotherapy (Florence, Italy) (2024)
Kazuhiro Kobayashi, Atsuko Hata, Waki Imoto, Shigeki Kakuno, Wataru Shibata, Koichi Yamada, Hiroshi Kawaguchi, Norihiro Sakurai, Toshikazu Ito, Kazuya Uenoyama, Tamotsu Takahashi, Satoru Ueda, Toshiro Katayama, Masahide Onoue, Hiroshi Kakeya
Evaluation of predictors of third-generation cephalosporin non-susceptibility and factors affecting recurrence or death in bacteremia caused by Citrobacter freundii complex , Enterobacter cloacae complex, and Klebsiella aerogenes . Journal of chemotherapy (Florence, Italy) (2024)
Anil Yıldiz, Ahmet Bilici, Ozgur Acikgoz, Jamshid Hamdard, Pelin Basim, Tansel Cakir, Asli Cakir, Omer Fatih Olmez, Cem Gezen, Ozcan Yildiz
Prognostic implications of response to neoadjuvant chemotherapy in breast cancer subtypes. Journal of chemotherapy (Florence, Italy) (2024)
Jamshid Hamdard, Ahmet Bilici, Abdullah Sakin, Seda Kahraman, Ayse Irem Yasin, Ender Kalaci, Ivo Gokmen, Ozgur Acikgoz, Yasin Kutlu, Mehmet Ali Nahit Sendur, Omer Fatih Olmez, Mesut Seker
Characteristic features and prognostic factors in gastric cancer patients with bone metastases: multicenter experience. Journal of chemotherapy (Florence, Italy) (2024)
Sabiha Gul, Raffaella Gallo, Lorenzo Bertolino, Fabian Patauner, Salvatore Buono, Rosanna De Rosa, Clelia Esposito, Nicola Galdieri, Arta Karruli, Domenico Iossa, Eugenio Piscitelli, Roberto Andini, Antonio Corcione, Emanuele Durante-Mangoni
Pharmacokinetic parameters of CAZ-AVI in the normal lung and in models of pneumonia: lessons for treatment optimization in critical care. Journal of chemotherapy (Florence, Italy) (2024)
Indrani Biswas, Daisy Precilla S, Shreyas S Kuduvalli, Bhavani K, Sivachandran R, Anitha T S
Ultrastructural and immunohistochemical insights on the anti-glioma effects of a dual-drug cocktail in an in vivo experimental model. Journal of chemotherapy (Florence, Italy) (2024)
Xiao-Chen Wei, Yuan-Yuan Guo, Yi Zhang, Yi-Shan Bu, Feng-Ying Zhang
Factors associated with immune-related thyroid dysfunction induced by PD-1/PD-L1 inhibitors in cancer patients: an observational study. Journal of chemotherapy (Florence, Italy) (2024)
Mustafa Wasifuddin, Nosakhare Paul Ilerhunmwuwa, Henry Becerra, Narek Hakobyan, Saad Wasifuddin, Hayder Al Asadi, Jen Chin Wang
Review of real-world experience with lurbinectedin in relapsed/refractory small cell lung cancer. Journal of chemotherapy (Florence, Italy) (2024)
Mohammad Amin Manavi, Mohammad Hosein Fathian Nasab, Razieh Mohammad Jafari, Ahmad Reza Dehpour
Mechanisms underlying dose-limiting toxicities of conventional chemotherapeutic agents. Journal of chemotherapy (Florence, Italy) (2024)
Jing-Jing Chen, Peng Shi, Zhi-Chao Cui, Nan Jiang, Jie Ma
CircRNA_0044556 affects the sensitivity of triple-negative breast cancer cells to paclitaxel by regulating miR-665. Journal of chemotherapy (Florence, Italy) (2024)
Jasmine Gill, John Walker, Carrie Ye
Elevated CK from immune checkpoint inhibitor- related hypophysitis: a case report. Journal of chemotherapy (Florence, Italy) (2024)

volume 36, number 1, 2024

Katerina Apostolaki, Lazaros A Gagaletsios, Costas C Papagiannitsis, Efthimia Petinaki
Macrolides impact the growth ability of clinical Pseudomonas aeruginosa through quorum-sensing systems. Journal of chemotherapy (Florence, Italy) 36 (1) (2024)
Katerina Apostolaki, Lazaros A Gagaletsios, Costas C Papagiannitsis, Efthimia Petinaki
Macrolides impact the growth ability of clinical Pseudomonas aeruginosa through quorum-sensing systems. Journal of chemotherapy (Florence, Italy) 36 (1) (2024)

volume 36, number 5, 2024

Joseph M Blondeau, Leah D Blondeau, Shantelle D Fitch
In vitro killing of drug susceptible and multidrug resistant bacteria by amikacin considering pulmonary drug concentrations based on an inhaled formulation. Journal of chemotherapy (Florence, Italy) 36 (5) (2024)
Joseph M Blondeau, Leah D Blondeau, Shantelle D Fitch
In vitro killing of drug susceptible and multidrug resistant bacteria by amikacin considering pulmonary drug concentrations based on an inhaled formulation. Journal of chemotherapy (Florence, Italy) 36 (5) (2024)
Avner Dagan, Danny Epstein, Ami Neuberger, Jonathan Isenberg
Amikacin treatment in urinary tract infection patients: evaluating the risk of acute kidney injury - a retrospective cohort study. Journal of chemotherapy (Florence, Italy) 36 (5) (2024)
Avner Dagan, Danny Epstein, Ami Neuberger, Jonathan Isenberg
Amikacin treatment in urinary tract infection patients: evaluating the risk of acute kidney injury - a retrospective cohort study. Journal of chemotherapy (Florence, Italy) 36 (5) (2024)